349 related articles for article (PubMed ID: 23463709)
21. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.
Garbuglia AR; Piselli P; Lapa D; Sias C; Del Nonno F; Baiocchini A; Cimaglia C; Agresta A; Capobianchi MR
J Clin Virol; 2012 Jun; 54(2):141-6. PubMed ID: 22437054
[TBL] [Abstract][Full Text] [Related]
22. High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women.
Heard I; Etienney I; Potard V; Poizot-Martin I; Moore C; Lesage AC; Ressiot E; Crenn-Hebert C; Fléjou JF; Cubie H; Costagliola D; Darragh TM;
Clin Infect Dis; 2015 May; 60(10):1559-68. PubMed ID: 25645213
[TBL] [Abstract][Full Text] [Related]
23. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
[TBL] [Abstract][Full Text] [Related]
24. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
[TBL] [Abstract][Full Text] [Related]
26. Influence of age and CD4+ T cell counts on the prevalence of genital human papillomavirus infection among HIV-seropositive men who have sex with men in Taiwan.
Cheng SH; Chu FY; Lin YS; Hsueh YM
J Med Virol; 2012 Dec; 84(12):1876-83. PubMed ID: 23080490
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.
Grinsztejn B; Veloso VG; Levi JE; Velasque L; Luz PM; Friedman RK; Andrade AC; Moreira RI; Russomano F; Pilotto JH; Bastos FI; Palefsky J
Int J Infect Dis; 2009 Jan; 13(1):72-80. PubMed ID: 18632296
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
29. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
[TBL] [Abstract][Full Text] [Related]
30. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
Ahdieh L; Klein RS; Burk R; Cu-Uvin S; Schuman P; Duerr A; Safaeian M; Astemborski J; Daniel R; Shah K
J Infect Dis; 2001 Sep; 184(6):682-90. PubMed ID: 11517428
[TBL] [Abstract][Full Text] [Related]
32. Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV.
Zeier MD; Botha MH; Engelbrecht S; Machekano RN; Jacobs GB; Isaacs S; van Schalkwyk M; van der Merwe H; Mason D; Nachega JB
AIDS; 2015 Jan; 29(1):59-66. PubMed ID: 25387313
[TBL] [Abstract][Full Text] [Related]
33. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
[TBL] [Abstract][Full Text] [Related]
35. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
[TBL] [Abstract][Full Text] [Related]
37. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
Palacios R; Senise J; Vaz M; Diaz R; Castelo A
HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology.
Carcopino X; Bolger N; Henry M; Mancini J; Boubli L; Olive D; Cleary S; Prendiville W; Tamalet C
J Med Virol; 2011 Apr; 83(4):637-43. PubMed ID: 21328378
[TBL] [Abstract][Full Text] [Related]
40. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
